Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4353 | 1725 | 49.0 | 81% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1220 | 8650 | TRIMETAZIDINE//DIABETIC CARDIOMYOPATHY//PERHEXILINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PROGRAM INTEGRAT CARDIAC METAB | Address | 23 | 76% | 1% | 16 |
2 | HERITAGE MED 423 | Address | 19 | 70% | 1% | 16 |
3 | CARDIAC METABOLISM | Author keyword | 11 | 19% | 3% | 52 |
4 | MYOCARDIAL METABOLISM | Author keyword | 9 | 17% | 3% | 45 |
5 | CARDIAC INSULIN RESISTANCE | Author keyword | 8 | 100% | 0% | 5 |
6 | MALONYL COA DECARBOXYLASE | Author keyword | 7 | 36% | 1% | 16 |
7 | CARDIAC EFFICIENCY | Author keyword | 6 | 33% | 1% | 15 |
8 | GLUCOSE OXIDATION | Author keyword | 6 | 11% | 3% | 47 |
9 | CITRIC ACID CYCLE | Author keyword | 5 | 17% | 1% | 25 |
10 | CARDIAC LIPOTOXICITY | Author keyword | 4 | 67% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CARDIAC METABOLISM | 11 | 19% | 3% | 52 | Search CARDIAC+METABOLISM | Search CARDIAC+METABOLISM |
2 | MYOCARDIAL METABOLISM | 9 | 17% | 3% | 45 | Search MYOCARDIAL+METABOLISM | Search MYOCARDIAL+METABOLISM |
3 | CARDIAC INSULIN RESISTANCE | 8 | 100% | 0% | 5 | Search CARDIAC+INSULIN+RESISTANCE | Search CARDIAC+INSULIN+RESISTANCE |
4 | MALONYL COA DECARBOXYLASE | 7 | 36% | 1% | 16 | Search MALONYL+COA+DECARBOXYLASE | Search MALONYL+COA+DECARBOXYLASE |
5 | CARDIAC EFFICIENCY | 6 | 33% | 1% | 15 | Search CARDIAC+EFFICIENCY | Search CARDIAC+EFFICIENCY |
6 | GLUCOSE OXIDATION | 6 | 11% | 3% | 47 | Search GLUCOSE+OXIDATION | Search GLUCOSE+OXIDATION |
7 | CITRIC ACID CYCLE | 5 | 17% | 1% | 25 | Search CITRIC+ACID+CYCLE | Search CITRIC+ACID+CYCLE |
8 | CARDIAC LIPOTOXICITY | 4 | 67% | 0% | 4 | Search CARDIAC+LIPOTOXICITY | Search CARDIAC+LIPOTOXICITY |
9 | ISOTOPOMER ANALYSIS | 4 | 30% | 1% | 12 | Search ISOTOPOMER+ANALYSIS | Search ISOTOPOMER+ANALYSIS |
10 | NMR ISOTOPOMER ANALYSIS | 4 | 75% | 0% | 3 | Search NMR+ISOTOPOMER+ANALYSIS | Search NMR+ISOTOPOMER+ANALYSIS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LIPOTOXIC CARDIOMYOPATHY | 56 | 55% | 4% | 71 |
2 | MALONYL COA LEVELS | 38 | 93% | 1% | 14 |
3 | MYOCARDIAL FATTY ACID | 33 | 63% | 2% | 33 |
4 | MYOCARDIAL SUBSTRATE METABOLISM | 31 | 52% | 2% | 42 |
5 | SUBSTRATE METABOLISM | 28 | 28% | 5% | 86 |
6 | GLUCOSE OXIDATION | 27 | 25% | 5% | 92 |
7 | ISOLATED WORKING HEARTS | 23 | 60% | 1% | 25 |
8 | CARDIAC EFFICIENCY | 22 | 49% | 2% | 33 |
9 | MYOCARDIAL TRIGLYCERIDE TURNOVER | 19 | 80% | 1% | 12 |
10 | REDUCED CARDIAC EFFICIENCY | 19 | 74% | 1% | 14 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Myocardial Fatty Acid Metabolism in Health and Disease | 2010 | 290 | 604 | 38% |
Myocardial substrate metabolism in the normal and failing heart | 2005 | 630 | 434 | 36% |
Mechanisms of disease - The failing heart - An engine out of fuel | 2007 | 606 | 103 | 25% |
Lipid Metabolism and Toxicity in the Heart | 2012 | 44 | 90 | 59% |
Glucose metabolism and cardiac hypertrophy | 2011 | 50 | 103 | 61% |
Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy | 2014 | 9 | 76 | 57% |
Cardiac Metabolism and its Interactions With Contraction, Growth, and Survival of Cardiomyocytes | 2013 | 29 | 208 | 45% |
Cardiac Metabolism in Heart Failure Implications Beyond ATP Production | 2013 | 34 | 142 | 37% |
Remodeling of Glucose Metabolism Precedes Pressure Overload-Induced Left Ventricular Hypertrophy: Review of a Hypothesis | 2015 | 1 | 41 | 54% |
Insulin-resistant cardiomyopathy | 2008 | 141 | 114 | 37% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROGRAM INTEGRAT CARDIAC METAB | 23 | 76% | 0.9% | 16 |
2 | HERITAGE MED 423 | 19 | 70% | 0.9% | 16 |
3 | PREVENT MED NUTR | 4 | 19% | 1.0% | 17 |
4 | MAZANKOWSKI ALBERTA HEART | 4 | 10% | 1.9% | 33 |
5 | HERITAGE MED 474 | 3 | 50% | 0.2% | 4 |
6 | PROGRAM HUMAN MOL BIOL GENET | 2 | 11% | 1.3% | 22 |
7 | CARDIOVASC TRANSLAT SCI | 2 | 67% | 0.1% | 2 |
8 | MODELLING INTEGRATED METAB SYST | 2 | 67% | 0.1% | 2 |
9 | METHODIST DIABET METAB | 2 | 50% | 0.2% | 3 |
10 | NMR DEV | 2 | 31% | 0.3% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000211480 | GLUCOSE INSULIN POTASSIUM//THORAC PHYSIOL//GIK |
2 | 0.0000159221 | TRIMETAZIDINE//TRIMETAZIDINE MB//TRIMETASIDINE |
3 | 0.0000159081 | CARDIAC SPECTROSCOPY//CARDIAC MAGNETIC RESONANCE SPECTROSCOPY//HIGH ENERGY PHOSPHATE |
4 | 0.0000137386 | ANTIDIABETIC PHARMACOTHERAPY//CHAIR GERIATR SURG//HEART FAILURE INCOR |
5 | 0.0000126494 | DIABETIC CARDIOMYOPATHY//DIABETIC HEART//ENVIRONM OCCUPAT AGR HLTH |
6 | 0.0000110334 | NODOSE PLACODE//MYOCARDIAL LAYERS//EXTRA LOAD |
7 | 0.0000101263 | OBESITY CARDIOMYOPATHY//CARDIAC REHABIL CARDIOVASC DIS//OXFORD CLIN CARDIOVASC IL |
8 | 0.0000096864 | MILDRONATE//MET 88//GAMMA BUTYROBETAINE HYDROXYLASE INHIBITOR |
9 | 0.0000090794 | IODINE 123 BMIPP//BMIPP//I 123 BMIPP |
10 | 0.0000085471 | GLYCEROL OUTPUT//OXFENICINE//METHYLPALMOXIRATE |